bms-986489
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 31, 2025 (NCT06646276)
Timeline
Indications
Studied for
Mechanism of action
- Fucosyl-GM1INHIBITOR
Fucosyl-GM1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06799286 | Phase 1 | Jul 31, 2025 | Bristol-Myers Squibb |
| NCT06773910 | Phase 2 | Mar 31, 2025 | Bristol-Myers Squibb, SCRI Development Innovations |
| NCT06646276 | Phase 3 | Jan 31, 2025 | Bristol-Myers Squibb |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 3 | 2 | 3 | 2025 |
| SCRI Development Innovations | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1